655 ml of 25 mM phosphate buffer (pH 7 4), 5 μl (0 02-0 04 mg pro

655 ml of 25 mM phosphate buffer (pH 7.4), 5 μl (0.02-0.04 mg protein) PF-01367338 clinical trial of a cellular solution, 100 μl of an enzymatic mix containing glucose oxidase (Aspergillus niger) (80 units/2 ml) and catalase (bovine liver) (500 units/2 ml), 90 μl of 1 M Alvocidib manufacturer sodium succinate and 100 μl of 320 mM glucose. Once a steady base line was observed, 50 μl of a saturated NO solution

(1.91 mM at 20°C) was added to the cuvette to start the reaction. Each assay was continued until NO detection dropped to zero (when all of the NO was consumed). Nitrous oxide determination E. meliloti cells were incubated in MMN with an initial O2 concentration of 2% in the headspace or anoxically. After 18 or 36 h of incubation, 500-μl gaseous aliquots were taken from the culture headspaces to determine the N2O level. In anoxic cultures (filled tubes), headspace was created by transferring 10 ml of liquid culture into a 20-ml headspace vial (Supelco®). Gas–liquid phase equilibration was performed by incubating the vials for 2 h at 30°C and at 185 rpm. To stop cell growth, 200 μl of 1 mg · ml-1 HgCl2 was added to each vial. The N2O production in liquid cultures was corrected using the dissolved N2O Bunsen solubility coefficient (47.2% at 30°C). Then, N2O was measured with a gas chromatograph type HP 4890D equipped with an electron capture detector (ECD). The column was packed with Porapak Q 80/100 MESH (6 ft), and the

carrier gas was N2 at a flow rate of 23 ml/min. The injector, column and detector temperatures were 125, 60 and 375°C, respectively. The N2O peaks were integrated using GC ChemStation Software (Agilent Technologies© PCI-32765 cell line 1990–2003). The samples Erlotinib mouse were injected manually through a Hamilton® Gastight syringe. The concentrations of N2O in each sample were calculated from pure nitrous oxide standards (Air Liquid, France). Quantitative real-time PCR analysis For immediate stabilisation of the bacterial RNA, the RNAprotect Bacteria Reagent (Qiagen Valencia, CA, USA) was added directly to cells incubated for 12 h in MM or MMN with an initial headspace O2 concentration of 2% or anoxically. Bacterial

lysis was performed by resuspension and incubation of the cell pellet in 1 mg/ml lysozyme from chicken egg whites (Sigma-Aldrich) in Tris-EDTA buffer, pH 8.0. The total RNA was isolated using the RNeasy Mini kit (Qiagen). The isolated RNA was subjected to DNase (Qiagen) treatment. The RNA was quantified using a NanoDrop 1000 Spectrophotometer (Thermo Scientific, USA), and intactness was verified by the visual inspection of rRNA bands in electrophoretically separated total RNA [48]. Reverse transcription reactions were performed with 0.8 μg of total RNA per reaction using the First Strand cDNA Synthesis kit for RT-PCR (Roche) with random hexamers. The cDNA synthesis reaction mixture was diluted 50 times with distilled water before use in real-time PCR analysis. The primers for the PCR reactions were designed using Primer Express v3.

Comments are closed.